When it comes to health care, the major concern is unfortunately not always patient care first but rather the economic strain. Money and financial needs is a factor that as a society we have yet to rectify the issue of health care for our population as a whole. This is especially true for out aging population not only in the United States but worldwide. There are a vast number of individuals who do not have access to health care to cover their medical needs and this leads to a plethora of problems down the line. Patients suffering from Parkinson’s disease are no exception to the need for adequate and affordable health care. In the European derived patients, Parkinson’s disease is increasing every year with 20 new cases per 100,000 patients. In the older population, that number increases to 160 per 100,000. The disease rate does not change over sex or location of country. With the number of people affected, it stands to say that we must begin to examine the public impact. In 1998, the direct costs for a patient with Parkinson’s disease in the United Kingdom were evaluated. The economic impact was evaluated in 1988-1989 and found that the overall cost for Parkinson’s Disease was £126 million ($141,390,900.00 US). A study in Germany was a bit more specific. A survey of 40 Parkinson’s disease patients resulted in data showing the average cost per outpatient was around DM 14,500 (about $8,314 US dollars). The breakdown for these costs are: 45% on drugs, 39% for inpatient treatment, 5% for outpatient visits, 4% on physiotherapy, and 8% on various other medical aids and appliances. A survey in the United States investigated the costs for 109 patients who were within five years of their diagnosis. The total annual cost was close to $6,000 in the year 1995. A large portion of this was wages lost for those who were unable to continue to work. It was also found that the